• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Arraras J, Illarramendi J, Manterola-Burgaleta A, de la Cruz S, Zarandona U, Ibañez B, Salgado E, Visus I, Barrado M, Teijeira L, Martinez E, Vera R. Quality of Life of breast cancer patients with COVID-19 disease. Eur J Cancer 2022. [PMCID: PMC9671787 DOI: 10.1016/s0959-8049(22)01515-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
2
Arraras J, Manterola A, Illarramendi J, Asin G, Campo M, De la Cruz S, Zarandona U, Ibañez B, Rico M, Salgado E, Dominguez M, Barrado M, Martinez E. PO-1287: Quality of life (QL) in elderly breast cancer survivors. Effects of surgery. Global QL determinants. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)01305-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
3
Arraras J, Illarramendi J, Manterola A, De la Cruz S, Asin G, Salgado E, Campos M, Barrado M, Ibañez B, Zarandona U, Rico M, Dominguez M, Sola A, Martinez E. Quality of life (QL) in elderly breast cancer survivors. Effects of surgery. Global QL determinants. Eur J Cancer 2020. [DOI: 10.1016/s0959-8049(20)30682-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
4
Arraras J, Manterola A, Illarramendi J, Asin G, Salgado E, De la Cruz S, Ibañez B, Vera R, Dominguez M. EP-1265: Quality of Life in long term premenopausic early stages breast cancer survivors. QL determinants. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31575-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
5
Ortega V, Lao J, Garau I, Afonso N, Calvo L, Fernández Y, Martinez-Garcia M, Blanco E, Zamora P, García M, Illarramendi J, Rodríguez C, Aguirre E, Pérez J, Castan JC, Llombart-Cussac A. MERIBEL study: Single-agent eribulin as first-line therapy for taxane-resistant HER2[-] metastatic breast cancer (MBC) patients (pts). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw365.17] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
6
Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Córdoba A, Vicente-García F, Illarramendi J, Blanco-Luquin I, Pernaut-Leza E, Guerrero-Setas D. CHL1 methylation may act as a tumour suppressor gene and predicts poor prognosis in breast cancer. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)61661-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
7
Boni V, Vega JL, Calvo EG, Plazaola A, Hernando B, Morales S, Anton A, Gomez RS, Illarramendi J, Garcia-foncillas J. 1093 POSTER Gene Signature of Bevacizumab Effects in Primary Breast Cancer. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)70736-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
8
Illarramendi J, Salgado E, Lainez N, Arrazubi V, Teijeira L, Vera R. Metástasis orbitarias del cáncer de mama. An Sist Sanit Navar 2008. [DOI: 10.4321/s1137-66272008000600012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
9
Larumbe A, Iglesias M, Illarramendi J, Córdoba A, Gallego M. Acral Keratoses and Inverted Follicular Keratosis Presenting as Cowden Disease. Actas Dermo-Sifiliográficas (English Edition) 2007. [DOI: 10.1016/s1578-2190(07)70476-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]  Open
10
Bayo J, Mayordomo J, Sanchez Rovira P, Gonzalez E, Garcia Bueno J, Ramos M, Crespo C, Illarramendi J, Valerdi J, Garcia Palomo A. Trastuzumab and vinorelbine combination in the treatment of metastatic breast cancer. EJC Suppl 2004. [DOI: 10.1016/s1359-6349(04)90857-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]  Open
11
Vera R, Martínez M, Salgado E, Láinez N, Illarramendi J, Albístur J. Tratamiento de la emesis inducida por quimioterapia. An Sist Sanit Navar 2004. [DOI: 10.4321/s1137-66272004000600012] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
12
Arias F, Valcayo A, Illarramendi J, Martinez K, Duenas M, Dominguez M. Acral erythema and intrahepatic 5-fluorouracil infusion. J Eur Acad Dermatol Venereol 1997. [DOI: 10.1111/j.1468-3083.1997.tb00494.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
13
Tejedor M, Molina F, Valerdi J, Dominguez M, Illarramendi J, Arias F, Martinez E. 697Hyperfractionated radiotherapy associated with hydroxyurea for high-grade malignant gliomas. Radiother Oncol 1996. [DOI: 10.1016/s0167-8140(96)80706-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
14
Arias F, Duenas M, Dominguez M, Martinez E, Illarramendi J, Villafranca E, Meirino R, Tejedor M, Molina F, Migueliz S, Valerdi J. 376Split hyperfractionated accelerated radiation therapy (shart) for locally advanced laryngeal carcinoma as an organ-sparing approach. Radiother Oncol 1996. [DOI: 10.1016/s0167-8140(96)80385-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
15
Duenas M, Arias F, Villafranca R, Martinez E, Meirino R, Dominguez M, Illarramendi J, Miguélez S, Tejedor M, Molina F, Valerdi J. 653Bladder cancer in elderly patients. Local control and survival after chemoradiotherapy. A real option? Radiother Oncol 1996. [DOI: 10.1016/s0167-8140(96)80662-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
16
Martínez E, Arias F, Domínguez M, Illarramendi J, López R, Tejedor M, Larrínaga B, Almudevar E, Rubio A, Soto P, Valerdi J. Predictive value of DNA content in head and neck carcinoma (HNC) treated with hyperfrationated radiotherapy (HRT). Eur J Cancer 1993. [DOI: 10.1016/0959-8049(93)91442-n] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
17
Valerdi J, Tejedor M, Domínguez M, Arias F, Illarramendi J, Martínez E, López R. Chemotherapy and hyperfractionated radiotherapy in stage III non-small cell lung cancer (NSCLC). Eur J Cancer 1993. [DOI: 10.1016/0959-8049(93)91549-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA